Clinical trial · Observational
Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine Patients
Prevalence of the Mutational Status of KRAS in mCRC in Argentine Patients
NCT01082757CI-TRIAL-00015276completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This observational, prospective, multicentric study is being conducted to record the prevalence of KRAS mutations in the Argentine mCRC population.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Neoplasms | Colorectal Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Mutational status of KRAS: study of codons 12 and 13 in exon 1 of KRAS gene
- timeFrame
- Initial visit (Day 1) and subsequent visit till the end of the study
Secondary outcomes (1)
- measure
- Subject and tumour characteristics and their association with KRAS mutational status
- timeFrame
- Initial visit (Day 1) and subsequent visit till the end of the study
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 22 Years
Show eligibility criteria text
Inclusion Criteria: * Subjects who have signed written informed consent before any study-related procedure * Subjects with histologically confirmed adenocarcinoma of the colon/ rectum, T1-4 N0-2 M1 or rT1-4 N0-2 M1 * Subjects with age above 21 years * Subjects willing to provide information required by protocol * No previous systemic treatment for mCRC Exclusion Criteria: * Subjects with known pregnancy * Subjects with previous systemic therapy for mCRC * Subjects with active infection or any other serious condition which, in the investigator´s mind, may render the subject ineligible for the study * Subjects with medical or psychological condition, which, in the opinion of the investigator, would not permit the subject to sign meaningful informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.